TherapeuticsMD, Inc. Quarterly Return On Equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
TherapeuticsMD, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q2 2024.
  • TherapeuticsMD, Inc. Return On Equity for the quarter ending June 30, 2024 was -21.4 %, a 106% decline year-over-year.
  • TherapeuticsMD, Inc. annual Return On Equity for 2023 was -34.1 %, a 86.3% increase from 2022.
  • TherapeuticsMD, Inc. annual Return On Equity for 2022 was -249 %, a 176% decline from 2021.
  • TherapeuticsMD, Inc. annual Return On Equity for 2021 was 329 %, a 70.1% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -21.4 -363 -106% Apr 1, 2024 Jun 30, 2024
Q1 2024 -25.3 +8.76K +99.7% Jan 1, 2024 Mar 31, 2024
Q4 2023 -34.1 +215 +86.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 216 +205 +1824% Jul 1, 2023 Sep 30, 2023
Q2 2023 341 +307 +899% Apr 1, 2023 Jun 30, 2023
Q1 2023 -8.78K -9K -4208% Jan 1, 2023 Mar 31, 2023
Q4 2022 -249 -578 -176% Oct 1, 2022 Dec 31, 2022
Q3 2022 11.2 -275 -96.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 34.2 -176 -83.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 214 +20.5 +10.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 329 +136 +70.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 286 -24.2 -7.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 210 -293 -58.2% Apr 1, 2021 Jun 30, 2021
Q1 2021 193 -1.38K -87.7% Jan 1, 2021 Mar 31, 2021
Q4 2020 194 +1.43K Oct 1, 2020 Dec 31, 2020
Q3 2020 310 +768 Jul 1, 2020 Sep 30, 2020
Q2 2020 503 +729 Apr 1, 2020 Jun 30, 2020
Q1 2020 1.57K +1.73K Jan 1, 2020 Mar 31, 2020
Q4 2019 -1.24K -1.11K -875% Oct 1, 2019 Dec 31, 2019
Q3 2019 -458 -356 -348% Jul 1, 2019 Sep 30, 2019
Q2 2019 -226 -145 -180% Apr 1, 2019 Jun 30, 2019
Q1 2019 -160 -92.9 -139% Jan 1, 2019 Mar 31, 2019
Q4 2018 -127 -63.7 -100% Oct 1, 2018 Dec 31, 2018
Q3 2018 -102 -37 -56.8% Jul 1, 2018 Sep 30, 2018
Q2 2018 -80.8 -6.5 -8.75% Apr 1, 2018 Jun 30, 2018
Q1 2018 -66.8 -1.41 -2.16% Jan 1, 2018 Mar 31, 2018
Q4 2017 -63.7 -6.09 -10.6% Oct 1, 2017 Dec 31, 2017
Q3 2017 -65.2 -4.79 -7.94% Jul 1, 2017 Sep 30, 2017
Q2 2017 -74.3 -9.94 -15.5% Apr 1, 2017 Jun 30, 2017
Q1 2017 -65.4 +22.6 +25.7% Jan 1, 2017 Mar 31, 2017
Q4 2016 -57.6 +59.2 +50.7% Oct 1, 2016 Dec 31, 2016
Q3 2016 -60.4 +60.9 +50.2% Jul 1, 2016 Sep 30, 2016
Q2 2016 -64.3 +60.9 +48.6% Apr 1, 2016 Jun 30, 2016
Q1 2016 -88 +23.2 +20.9% Jan 1, 2016 Mar 31, 2016
Q4 2015 -117 -6.29 -5.69% Oct 1, 2015 Dec 31, 2015
Q3 2015 -121 -46.4 -62% Jul 1, 2015 Sep 30, 2015
Q2 2015 -125 -85.3 -213% Apr 1, 2015 Jun 30, 2015
Q1 2015 -111 -93 -510% Jan 1, 2015 Mar 31, 2015
Q4 2014 -111 -110 Oct 1, 2014 Dec 31, 2014
Q3 2014 -74.9 -74.8 Jul 1, 2014 Sep 30, 2014
Q2 2014 -40 -39.9 Apr 1, 2014 Jun 30, 2014
Q1 2014 -18.2 -17.9 Jan 1, 2014 Mar 31, 2014
Q4 2013 -0.06* -1.49 Oct 1, 2013 Dec 31, 2013
Q3 2013 -0.07* -381 Jul 1, 2013 Sep 30, 2013
Q2 2013 -0.12* -716 Apr 1, 2013 Jun 30, 2013
Q1 2013 -0.34* -832 Jan 1, 2013 Mar 31, 2013
Q4 2012 1.43* Oct 1, 2012 Dec 31, 2012
Q3 2012 381* Jul 1, 2012 Sep 30, 2012
Q2 2012 716* Apr 1, 2012 Jun 30, 2012
Q1 2012 832* Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.